Scholarlink

<p>Michimoto et al. demonstrated superior prognostic performance of MELD 3.0 for elective TIPS. While findings support improved risk stratification, lack of data on patients not undergoing TIPS and exclusion of key clinical outcomes limit immediate applicability. Broader validation and inclusion of post-TIPS complications are needed to guide patient selection and treatment decisions effectively.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Comment on “Prognostic Performance of Model for End-Stage Liver Disease (MELD) 3.0 for Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation”

  • 期刊论文

  • 发表日期：

    2025年8月26日

查看全文
  • Tanjima Tarique Laskar,
  • Sudarshana Borah,
  • Monica Arora

摘要

Michimoto et al. demonstrated superior prognostic performance of MELD 3.0 for elective TIPS. While findings support improved risk stratification, lack of data on patients not undergoing TIPS and exclusion of key clinical outcomes limit immediate applicability. Broader validation and inclusion of post-TIPS complications are needed to guide patient selection and treatment decisions effectively.